ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

SURVEY: Cognitive Impairment II

Natural Bladder Control, Go Less and Live More

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Top Vitamin and Mineral Deficiencies — Are You at Risk?

How Pomegranate May Protect Against Cancer

Omega Fix for Obesity: How the Right Fats Fight Fat

Trimming the spare tire: Canola oil may cut belly fat

The Onion: Cancer Fighter and Food Preserver

Fighting Heartburn and Gerd Naturally – And Safely!

Probiotics improve cognition in Alzheimer's patients

 
Print Page
Email Article

Non-Invasive MRI Technique Distinguishes Between Alzheimer's and Frontotemporal Dementia

  [ 86 votes ]   [ Discuss This Article ]
www.ProHealth.com • June 29, 2005


Source: University of California - San Francisco Arterial spin labeling distinguishes between Alzheimer’s disease and frontotemporal dementia A non-invasive magnetic resonance imaging (MRI) technique called arterial spin labeling is just as accurate as invasive scanning techniques in distinguishing Alzheimer's disease from frontotemporal dementia (FTD) in the brains of elderly people, according to a new study at the San Francisco VA Medical Center (SFVAMC). The study, led by Norbert Schuff, PhD, a Principle Investigator at SFVAMC, used arterial spin labeling to measure perfusion, or blood flow, in the areas of the brain affected by the two diseases. "Blood flow indicates brain activation," said Dr. Schuff. "So the area with less blood flow is the area affected by disease." In the study, arterial spin labeling successfully distinguished between Alzheimer's patients, FTD patients, and people without dementia. Antao Du, PhD, SFVAMC Research Scientist and study co-author, is presenting the results at the first International Conference on Prevention of Dementia, which is being held June 18-21 in Washington, D.C. The conference is sponsored by the Alzheimer's Association. Frontotemporal dementia is a degenerative condition involving the front part of the brain. It is the second-most common dementia after Alzheimer's disease, which mainly affects other brain areas such as the hippocampus and the temporal lobe. In their early stages, the two diseases present similar symptoms, making accurate diagnosis difficult, said Schuff, who is also an associate professor of radiology at the University of California, San Francisco (UCSF). In its later stages, FTD affects social conduct, social inhibitions, and personality, while Alzheimer's is a progressive impairment of multiple cognitive functions, often involving memory decline. "Progression of frontotemporal dementia is usually faster than Alzheimer's, and the underlying pathology is different, so it is important to know the difference," Schuff observed. Currently, brain blood flow can be measured using positron emission tomography (PET) and single proton emission computerized tomography (SPECT). However, these techniques involve injecting patients with radioactive tracers. In addition, Schuff noted, they can be expensive -- about $2,000 for a PET scan -- can take up to half a day to perform, and are not widely available. "So if you can acquire blood flow information with MRI, that would be very beneficial. MRI is totally non-invasive, making it much safer for patients. It's more widely available, it's cheaper, and arterial spin labeling can be done in ten minutes together with a conventional MRI scan." In simple terms, MRI is a non-radioactive imaging technique that measures the magnetic alignment of protons in the body. In arterial spin labeling, a technique invented by researchers at the University of Pennsylvania, protons in arterial blood are magnetically aligned in the opposite direction from the rest of the protons in blood and brain tissue. By measuring the intensity of the magnetic signal from these so-called inversely polarized protons when they reach the brain, researchers can calculate the amount of blood flow, and thus neuron activity, in a particular section of the brain. In the study, Schuff and his fellow researchers measured brain perfusion in 24 Alzheimer's patients, 21 FTD patients, and 25 control subjects without dementia. The subjects were 62 to 90 years old, with an average age of just under 63. They were studied using an MRI system with a magnetic field strength of 1.5 Tesla, a common system in clinics and hospitals in the United States. The researchers successfully used arterial spin labeling to replicate PET and SPECT data on brain perfusion in all subjects. They also found that the perfusion data, added to structural information about the brain obtained with conventional MRI, significantly improved the classification of FTD from normal aging. Thus, "we gained specificity and sensitivity," said Schuff. Schuff emphasized that because this was a research study, the aim of which was to accurately replicate PET and SPECT perfusion data, it did not prove that arterial spin labeling can be used to diagnose an individual patient. The next step for future research, he said, is to demonstrate that the perfusion abnormalities correlate with specific clinical symptoms. "At the moment, we have just dichotomized [patients] into Alzheimer's and FTD," he said. "But of course cognitive impairment is usually more complex -- you have a range of impairments." The technique has the potential to distinguish other types of dementia as well. Schuff plans to study a larger sample in a clinical setting, with the goal of determining whether this is possible. "Once we have a large database of images," he predicted, "we can better determine what is normal, and then compare an individual subject with this normal range." Schuff intends to continue his studies using a more powerful MRI system that operates at a magnetic field strength of 4 Tesla. This state-of-the art system was recently installed at SFVAMC with support funds from the National Institutes of Health (NIH) and the Department of Defense. "At 4 Tesla, measurements of brain blood flow will be more accurate than at 1.5 Tesla due to a higher signal intensity and prolonged lifetime of the polarized protons," Schuff said. Additional authors of the study are G.-H. Jahng, PhD, and Bruce Miller, MD, of UCSF; Sataru Hayasaka, PhD, of SFVAMC; Joel Kramer, MD, of UCSF; and Michael Weiner, MD, Director of the Magnetic Resonance Spectroscopy Unit at SFVAMC and professor of radiology, medicine, psychiatry, and neurology at UCSF. The research was funded by grants from the NIH that were administered by the Northern California Institute for Research and Education (NCIRE), and by a grant from the U.S. Department of Veterans Affairs.



Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Ultra EPA  - Fish Oil FibroSleep™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Complete and Natural Menopause Relief Complete and Natural Menopause Relief
Top 3 Nutrients to Detox the Liver and Soothe Digestion Top 3 Nutrients to Detox the Liver and Soothe Digestion
Natural Support for Mood, Sleep and Mental Focus? L-theanine Natural Support for Mood, Sleep and Mental Focus? L-theanine
A Hard-Working Molecule that May Help Ease Pain & Brighten Mood A Hard-Working Molecule that May Help Ease Pain & Brighten Mood
Aches and Pains? A Simple Solution You'll Love Aches and Pains? A Simple Solution You'll Love

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map